CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RBCE-GenoDiagnoSens aims to develop a low-cost, minimally-invasive diagnostic system using nanotechnology for early detection of DNA biomarkers in breast cancer. The project focuses on creating an array of nano-biosensors for analyzing circulating tumor cells, enhancing sensitivity and selectivity in cancer monitoring.
The overall objective of RBCE-GenoDiagnoSens is to exploit breakthroughs at the confluences of micro-, nano- and bio-technologies to initiate the creation of a low-cost minimally-invasive intelligent diagnosis system using a nanotechnology-based device for the early detection of DNA biomarkers involved in breast cancer, especially found in circulating tumour cells (CTCs).
The device will consist of an array of nano-biosensors for the consecutive RNA/DNA analysis of cancer cells.
The advantages o…
UNIVERSITAT ROVIRA I VIRGILI
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
